small-molecule drug discovery deals (Novartis)
90
Structured Review
Novartis
small-molecule drug discovery deals
Small Molecule Drug Discovery Deals, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small-molecule+drug+discovery+deals/small+molecule+drug+discovery+deals/pm39672955-161-25-30
Average 90 stars, based on 1 article reviews
Small Molecule Drug Discovery Deals, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small-molecule+drug+discovery+deals/small+molecule+drug+discovery+deals/pm39672955-161-25-30
Average 90 stars, based on 1 article reviews
small-molecule drug discovery deals - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Biopharma deals get smaller and earlier. Article Snippet: S o far in 2024, biopharma merger and acquisition (M&A) activity has been lackluster.. Granted, the previous year was always going to be a hard act to follow, with Pfizer’s $43 billion acquisition of Seagen and a flurry of other multi-billion-dollar transactions around late-stage or marketed drugs.. But with just $55 billion of biopharma M&A by the end of September 2024, full-year value is tracking at less than half of 2023’s total. |